ÂÜÀòÂÒÂ×

Christine Maurer currently serves as Chief Operating Officer at Capacity Bio, bringing a wealth of experience in development operations and regulatory affairs from previous roles at Autobahn Therapeutics, Inc. and Kiniksa Pharmaceuticals. At Autobahn Therapeutics, Christine played a crucial role in transitioning the company from preclinical to clinical stages, while at Kiniksa Pharmaceuticals, significant contributions were made to build a startup focused on rare autoinflammatory and autoimmune diseases. With additional leadership roles in program management and operations at Synageva Biopharma Corp. and Biogen Idec, Christine has demonstrated expertise in managing complex biopharmaceutical projects and successfully launching several clinical programs. Christine holds a Master’s degree in Project and Program Management from Brandeis University and a Bachelor’s degree in Business from Pace University.